Valley Forge Investment Consultants Inc Adv Silverback Therapeutics, Inc. Transaction History
Valley Forge Investment Consultants Inc Adv
- $290 Million
- Q4 2024
A detailed history of Valley Forge Investment Consultants Inc Adv transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Valley Forge Investment Consultants Inc Adv holds 83,225 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,225
Previous 83,225
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SBTX
# of Institutions
178Shares Held
70.1MCall Options Held
263KPut Options Held
299K-
Ra Capital Management, L.P. Boston, MA10.9MShares$00.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY10.5MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.29MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY4.08MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...